PFIZER MISSED DEADLINE TO TURN IN MYOCARDITIS DATA

Published: Feb. 17, 2023, 4:45 p.m.

Pfizer missed a deadline to turn over internal studies on myocarditis, per an FDA order. The deadline came and went. Now, they quietly have a new date in June. Why the delay on such important data? And, why does the FDA set arbitrary deadlines which aren\u2019t enforced?
#VRBPAC #Myocarditis #Deadline #FDA #Pfizer